REVVITY, INC Sale Leaseback Transaction, Current Period Gain Recognized
REVVITY, INC (RVTY) reported Sale Leaseback Transaction, Current Period Gain Recognized of $1.80 million for the 12-month period ending 2018-12-30, per its 10-K filed 2019-02-26.
Discontinued › Income Statement › Other Income
us-gaap:SaleLeasebackTransactionCurrentPeriodGainRecognized · last filed 2019-02-26
- REVVITY, INC sale leaseback transaction, current period gain recognized for the quarter ending 2014-12-28 was $500.00K.
- REVVITY, INC sale leaseback transaction, current period gain recognized for the quarter ending 2014-09-28 was $400.00K.
- REVVITY, INC sale leaseback transaction, current period gain recognized for the quarter ending 2014-06-29 was $500.00K.
- REVVITY, INC sale leaseback transaction, current period gain recognized for the quarter ending 2014-03-30 was $400.00K.
- REVVITY, INC sale leaseback transaction, current period gain recognized for fiscal 2018 was $1.80M, a 0.00% change from fiscal 2017.
- REVVITY, INC sale leaseback transaction, current period gain recognized for fiscal 2017 was $1.80M, a 0.00% change from fiscal 2017.
- REVVITY, INC sale leaseback transaction, current period gain recognized for fiscal 2017 was $1.80M, a 0.00% change from fiscal 2016.
- REVVITY, INC sale leaseback transaction, current period gain recognized for fiscal 2016 was $1.80M, a 0.00% change from fiscal 2014.
| Period end | Sale Leaseback Transaction, Current Period Gain Recognized 3 month | Sale Leaseback Transaction, Current Period Gain Recognized 6 month | Sale Leaseback Transaction, Current Period Gain Recognized 9 month | Sale Leaseback Transaction, Current Period Gain Recognized 12 month |
|---|---|---|---|---|
| 2018-12-30 | $1.80M 10-K · filed 2019-02-26 | |||
| 2017-12-31 | $1.80M 10-K · filed 2018-02-27 | |||
| 2017-01-01 | $1.80M 10-K · filed 2017-02-28 | |||
| 2016-01-03 | $1.80M 10-K · filed 2016-03-01 | |||
| 2014-12-28 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $900.00K derived: sum of 2 quarters · filed 2016-03-01 | $1.40M derived: sum of 3 quarters · filed 2016-03-01 | $1.80M 10-K · filed 2016-03-01 |
| 2014-09-28 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $900.00K derived: sum of 2 quarters · filed 2014-11-04 | $1.30M 10-Q · filed 2014-11-04 | |
| 2014-06-29 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $900.00K 10-Q · filed 2014-08-05 | ||
| 2014-03-30 | $400.00K 10-Q · filed 2014-05-06 | |||
| 2013-12-29 | $600.00K 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |